Cerenion Oy

We are proud to announce the launch of C-Trend® EEG Station in Europe! Continuous EEG is increasingly recommended in clinical guidelines for critically ill patients, including those after cardiac arrest, especially to detect seizures and support neurological outcome assessment. Yet in many hospitals, EEG monitoring remains difficult to access due to limited specialist availability and complex workflows. C-Trend EEG Station is designed to change that. By combining AI-powered EEG analysis, an easy-to-apply single-use electrode, and a complete bedside workstation, C-Trend EEG Station enables ICU teams to start monitoring brain activity quickly, even when EEG specialists are not immediately available. The system helps clinicians observe brain function trends, detect patterns such as seizures or burst suppression, and support faster diagnosis and treatment decisions directly at the bedside. Jukka Kortelainen, MD, PhD, CEO and Co-founder of Cerenion: "Our goal has always been to make EEG monitoring accessible for every ICU team caring for critically ill patients. With C-Trend EEG Station now available in Europe, we are taking an important step toward bringing practical, AI-supported brain monitoring to the bedside, helping clinicians gain visibility into brain function when it matters most." The launch is a significant milestone for us. Our vision is that unveiling the secrets of the brain will enable better care for critically ill patients. If you are interested in distribution partnerships, clinical collaboration, or bringing C-Trend to your hospital, we would love to connect. 👉 Learn more about C-Trend EEG Station and how it can support brain monitoring in acute care. Link in comments. #MedTech #ICU #EEG #NeuroMonitoring #CriticalCare #HealthcareInnovation

It was a true pleasure to be a part of Mondiag on Colours of Sepsis 2026! We were honored to host Cerenion Oy at the congress for the first time in Europe—a huge thank you to Kaisu Sutinen and Lyna Haybout for your invaluable participation. We were also delighted to be joined by Anton Balakirev from Deep Breath 🫁 . Presenting alongside such a talented group was a fantastic experience. See you all next year in Ostrava!

We are happy to announce that we have a new Clinical Manager onboard! Dr. Lyna Haybout has joined our ranks to help bring EEG monitoring to the hands of acute care doctors and nurses. Read more at https://lnkd.in/d7hmK_dz

We are pleased to be on site in San Francisco at the J.P. Morgan 2026 Healthcare Conference, together with our Chairman of the Board, Jon Unnérus, representing Cerenion Oy at one of the most influential gatherings in global healthcare. This conference brings together leaders, innovators, and investors who are shaping the future of health and life sciences, and we are proud to be part of that dialogue. At Cerenion, our mission is to transform neurological monitoring in intensive care and emergency settings by making EEG-based brain monitoring accessible to every clinician. With C-Trend®, our AI-powered solution translates complex brain data into simple, actionable insights supporting better and faster decision-making for patients in critical condition. We look forward to meaningful conversations with partners, investors, and fellow innovators on how we can together advance the standard of care in critical healthcare environments. If you’re attending and would like to connect, feel free to reach out. #JPMHealthcare #JPM2026 #BrainMonitoring #CriticalCare #IntensiveCare #EEG

I’m pleased to share our newly published article, “Accuracy of EEG Slow Wave Activity in Predicting Favorable Outcome in Patients with Hypoxic Brain Injury — A Protocol for a Substudy of the STEPCARE Trial”, now available in Acta Anaesthesiologica Scandinavica. 👉 https://lnkd.in/dumKzrxH The publication presents the protocol for the ongoing international substudy PROPEA STEPCARE of the STEPCARE trial evaluating how EEG slow wave activity (SWA) can be used in the prognostication of cardiac arrest survivors. Early and accurate evaluation of brain function after cardiac arrest is one of the major challenges in critical care. Reliable and practical tools are urgently needed to guide clinical decisions, support communication with families, and ensure that every patient with potential for recovery receives optimal care. From the very beginning, Cerenion Oy’s mission has been to bring practical, reliable, and easy-to-use EEG-based tools to intensive care units enabling clinicians to better understand brain function when it matters most. Our C-Trend solution is a direct result of this vision: an AI-driven approach for objective and straightforward interpretation of EEG activity, designed to make early brain monitoring accessible even in hospitals without constant availability of specialized neurophysiology expertise. This substudy marks another important step toward validating that approach in real-world critical care. My sincere thanks to all collaborators involved in this project for their dedication to advancing neurocritical care. #CTREND #EEG #Neuroprognostication #CardiacArrest #STEPCARE #CriticalCare #BrainMonitoring #ClinicalResearch #ICU #intensivecare

We are hiring a Clinical Manager! Are you a commercially minded nurse that is not afraid of technology and likes to work with people in an international setting? Read more and apply by Nov 14th! https://lnkd.in/dcjMCS6F

We're #hiring a new Clinical Manager either to Helsinki or Oulu. Are you a commercilly minded nurse who is not afraid of technology and likes to work with people in an international setting? We'd love to hear from you!

Meet Cerenion's new Product Manager: Terhimaria Kaski! https://lnkd.in/dyymNKvU

Launch ahoy! This year, the #ESICM Lives congress is also the opportunity to witness the first ever public appearance of the C-Trend EEG Station, Cerenion's brand new solution that makes EEG monitoring easier and more accessible than ever before. We will launch the product with orange prototype stickers, as C-Trend EEG Software, a part of the C-Trend EEG Station, is not yet CE marked or commercially available. We are working hard to change this soon! Come and meet team Cerenion at the booth, if you happen to be in Munich next week! Jukka Kortelainen, Timo Koskela, Terhimaria Kaski, Kaisu Sutinen. Read more at https://lnkd.in/esMEUA7q and https://lnkd.in/d2CXjDxK